Abstract
A concise and efficient route for the synthesis of indole derivatives having propellane structure at position 3 by simple regioselective one-pot reaction of ninhydrin, malononitrile, tryptamine, and β-dicarbonyl compounds was developed. This protocol provides an alternative method for application in combinatorial and parallel synthesis in drug discovery. The value of this method lies in its simplicity, regioselectivity, and good yields. The structures of new synthesized compounds were corroborated spectroscopically (IR, 1H- and 13C-NMR, and EI-MS). A plausible mechanism for this type of reaction is proposed (Scheme 2).
Keywords: Indole, propellane, tryptamin, ninhydrin, one-pot reaction.
Letters in Organic Chemistry
Title:Tandem One-Pot Synthesis of Indoles Having a Structural Moiety of Propellane
Volume: 12 Issue: 3
Author(s): Abdolali Alizadeh, Fahimeh Bayat and Vahideh Sadeghi
Affiliation:
Keywords: Indole, propellane, tryptamin, ninhydrin, one-pot reaction.
Abstract: A concise and efficient route for the synthesis of indole derivatives having propellane structure at position 3 by simple regioselective one-pot reaction of ninhydrin, malononitrile, tryptamine, and β-dicarbonyl compounds was developed. This protocol provides an alternative method for application in combinatorial and parallel synthesis in drug discovery. The value of this method lies in its simplicity, regioselectivity, and good yields. The structures of new synthesized compounds were corroborated spectroscopically (IR, 1H- and 13C-NMR, and EI-MS). A plausible mechanism for this type of reaction is proposed (Scheme 2).
Export Options
About this article
Cite this article as:
Alizadeh Abdolali, Bayat Fahimeh and Sadeghi Vahideh, Tandem One-Pot Synthesis of Indoles Having a Structural Moiety of Propellane, Letters in Organic Chemistry 2015; 12 (3) . https://dx.doi.org/10.2174/1570178612666150108003359
DOI https://dx.doi.org/10.2174/1570178612666150108003359 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
Recent Patents on Anti-Cancer Drug Discovery Functional PLGA NPs for Oral Drug Delivery: Recent Strategies and Developments
Mini-Reviews in Medicinal Chemistry Angiotensin-Converting Enzymes (ACE and ACE2) as Potential Targets for Malignant Epithelial Neoplasia: Review and Bioinformatics Analyses Focused in Oral Squamous Cell Carcinoma
Protein & Peptide Letters Management of Fallopian Tube Cancer
Reviews on Recent Clinical Trials Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets Inhibitory Effects of Novel SphK2 Inhibitors on Migration of Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Interactome Analysis of the Differentially Expressed Proteins in Uterine Leiomyoma
Anti-Cancer Agents in Medicinal Chemistry The Potential of Secondary Metabolites from Plants as Drugs or Leads Against Protozoan Neglected Diseases – Part I
Current Medicinal Chemistry Recent Patents on Imaging Nanoprobes for Brain Tumor Diagnosis and Therapy
Recent Patents on Biotechnology Targeting the EGF/HER Ligand-Receptor System in Cancer
Current Pharmaceutical Design Synthesis and Biological Evaluation of Quinazoline Derivatives as Potential Anticancer Agents (II)
Anti-Cancer Agents in Medicinal Chemistry The IGF-I/IGF-I Receptor Pathway: Implications in the Pathophysiology of Thyroid Cancer
Current Medicinal Chemistry Preclinical Molecular Imaging of the Translocator Protein (TSPO) in a Metastases Model Based on Breast Cancer Xenografts Propagated in the Murine Brain
Current Molecular Medicine Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem
Cardiovascular & Hematological Disorders-Drug Targets Human 5-HT4 and 5-HT7 Receptor Splice Variants: Are they Important?
Current Neuropharmacology Alternative Splice Variants of Survivin as Potential Targets in Cancer
Current Drug Discovery Technologies Targeting Breast Cancer Stem Cells: A Methodological Perspective
Current Stem Cell Research & Therapy MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer
Current Cancer Drug Targets Evaluation of In-Vivo Anti-Implantation and In-Vitro Anti-Proliferative Activities of Substituted 3-phenyl-4-phenylvinyl Benzopyranone Derivatives
Letters in Drug Design & Discovery Thymoquinone: Major Molecular Targets, Prominent Pharmacological Actions and Drug Delivery Concerns
Current Bioactive Compounds